Mainstay Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Mainstay Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$97.32 - $148.76 $9,732 - $14,876	-100 Closed	0 $0
Q2 2018 Aug 23, 2018	SELL	$71.74 - $153.69 $7,173 - $15,369	-100 Reduced 50.0%	100 $13,000
Q1 2018 May 10, 2018	SELL	$54.02 - $82.27 $5,402 - $8,227	-100 Reduced 33.33%	200 $14,000
Q4 2017 Mar 28, 2018	BUY	$47.64 - $56.75 $14,292 - $17,025	300	300 $17,000

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Mainstay Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mainstay Capital Management LLC with notifications on news.